{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T05:08:43Z","timestamp":1788930523650,"version":"build-2803163510"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Graves\u2019 orbitopathy (GO) is a complication of Graves\u2019 disease characterized by periorbital tissue inflammation, adipose tissue expansion, and fibrosis. The infiltration of immune cells into the periorbital tissue is thought to be a crucial factor in triggering the complication. Although orbital fibroblasts are considered to represent key cellular elements in the pathogenesis of GO, their interaction with immune cells is hardly explored. Here, we aimed to study\n                      <jats:italic>in vitro<\/jats:italic>\n                      the effects of autologous peripheral blood mononuclear cells (PBMCs) on orbital fibroblasts derived from GO patients with active\/inactive disease with or without steroids and vitamin D3.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Orbital fibroblasts and PBMCs collected from active and inactive GO patients were co-cultured for 48\u00a0h in the presence of vitamin D3 and\/or steroids (methylprednisolone, MP). Flow cytometric, quantitative PCR (qPCR), and immunoenzymatic assessments enabled evaluation of the changes during cell-to-cell interactions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We found that orbital fibroblasts from inactive GO exhibited higher expression of the genes associated with tissue remodeling. Co-culture of fibroblasts with PBMCs enhanced the proliferation rate of fibroblasts, especially the fibroblasts from active GO. Moreover, the cytokine secretion patterns and early changes in the deposition of extracellular matrix compounds by orbital fibroblasts were also found to differ between disease stages. In addition, we demonstrate that exposure to MP reduces fibroblast proliferation, particularly those derived from the inactive disease stage, and that the combination of MP with vitamin D3 suppresses IL-6 and CCL-20 secretion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>We propose that the pathogenesis of GO involves mutual interactions between orbital fibroblasts and immune cells, which may be disease stage-specific and can be modulated by MP and vitamin D3.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1728194","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T04:40:50Z","timestamp":1788928850000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["In vitro evaluation of the interaction between orbital fibroblasts and PBMCs from Graves\u2019 orbitopathy patients in triggering periorbital remodeling"],"prefix":"10.3389","volume":"17","author":[{"given":"Aleksandra","family":"Starosz","sequence":"first","affiliation":[{"name":"Department of Regenerative Medicine and Immune Regulation, Medical University of Bialystok","place":["Bialystok, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem A.","family":"Dik","sequence":"additional","affiliation":[{"name":"Laboratory Medical Immunology, Department of Immunology, Erasmus University Medical Center","place":["Rotterdam, Netherlands"]},{"name":"Laboratory Medical Immunology, Reinier Haga Medisch Diagnostisch Centrum (RHMDC)","place":["Delft, Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dion","family":"Paridaens","sequence":"additional","affiliation":[{"name":"Department of Oculoplastic, Lacrimal and Orbital Surgery, Rotterdam Eye Hospital","place":["Rotterdam, Netherlands"]},{"name":"Department of Ophthalmology, Erasmus Medical Center (MC) University Medical Center Rotterdam","place":["Rotterdam, Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Conny P. A.","family":"van Holten Neelen","sequence":"additional","affiliation":[{"name":"Laboratory Medical Immunology, Department of Immunology, Erasmus University Medical Center","place":["Rotterdam, Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Goes","sequence":"additional","affiliation":[{"name":"Department of Oculoplastic, Lacrimal and Orbital Surgery, Rotterdam Eye Hospital","place":["Rotterdam, Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Przemys\u0142aw","family":"Paw\u0142owski","sequence":"additional","affiliation":[{"name":"Department of Paediatric Ophthalmology and Strabismus, Medical University of Bialystok","place":["Bialystok, Poland"]},{"name":"Department of Medical Pathology, Cathedral of Biostructure, Medical University of Bialystok","place":["Bialystok, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamil","family":"Grubczak","sequence":"additional","affiliation":[{"name":"Department of Regenerative Medicine and Immune Regulation, Medical University of Bialystok","place":["Bialystok, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2020.101388","article-title":"Graves' disease: clinical manifestations, immune pathogenesis (cytokines and chemokines) and therapy","volume":"34","author":"Antonelli","year":"2020","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1510030","article-title":"Graves' disease","volume":"375","author":"Smith","year":"2016","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1056\/nejmra0905750","article-title":"Graves' ophthalmopathy","volume":"362","author":"Bahn","year":"2010","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1530\/eje-21-0479","article-title":"The 2021 European Group on Graves' orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves' orbitopathy","volume":"185","author":"Bartalena","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yexmp.2018.11.004","article-title":"Molecular biomarkers of Graves' ophthalmopathy","volume":"106","author":"Longo","year":"2018","journal-title":"Exp Mol Pathol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1089\/105072502761016476","article-title":"Epidemiology and prevention of Graves' ophthalmopathy","volume":"12","author":"Wiersinga","year":"2002","journal-title":"Thyroid"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2015-307399","article-title":"Pathogenesis of thyroid eye disease: review and update on molecular mechanisms","volume":"100","author":"Khong","year":"2016","journal-title":"Br J Ophthalmol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1062045","article-title":"A review of TSHR- and IGF-1R-related pathogenesis and treatment of Graves' orbitopathy","volume":"14","author":"Cui","year":"2023","journal-title":"Front Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14681","article-title":"TSH receptor specific monoclonal autoantibody K1-70","volume":"96","author":"Furmaniak","year":"2022","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B10","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.exer.2015.02.007","article-title":"Current perspectives on the role of orbital fibroblasts in the pathogenesis of Graves' ophthalmopathy","volume":"142","author":"Dik","year":"2016","journal-title":"Exp Eye Res"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.05-0605","article-title":"Autologous T-lymphocytes stimulate proliferation of orbital fibroblasts derived from patients with Graves' ophthalmopathy","volume":"46","author":"Feldon","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.18240\/ijo.2019.07.24","article-title":"The role of cell mediated immunopathogenesis in thyroid-associated ophthalmopathy","volume":"12","author":"Wang","year":"2019","journal-title":"Int J Ophthalmol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-018-0279-9","article-title":"The involvement of T cell pathogenesis in thyroid-associated ophthalmopathy","volume":"33","author":"Huang","year":"2019","journal-title":"Eye (Lond)"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.648732","article-title":"Mechanisms that underly T cell immunity in Graves' orbitopathy","volume":"12","author":"Fang","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-01626","article-title":"Insights into local orbital immunity: evidence for the involvement of the Th17 cell pathway in thyroid-associated ophthalmopathy","volume":"104","author":"Fang","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2003.035915","article-title":"Thyroid associated ophthalmopathy: evidence for CD4(+) gammadelta T cells; de novo differentiation of RFD7(+) macrophages, but not of RFD1(+) dendritic cells; and loss of gammadelta and alphabeta T cell receptor expression","volume":"88","author":"Eckstein","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa124","article-title":"Evidence for associations between Th1\/Th17 \"hybrid\" phenotype and altered lipometabolism in very severe Graves' orbitopathy","volume":"6","author":"Fang","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-00615-2","article-title":"A novel CD4+ CTL subtype characterized by chemotaxis and inflammation is involved in the pathogenesis of Graves' orbitopathy","volume":"18","author":"Wang","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1210\/endocr\/bqac203","article-title":"Macrophage-orbital fibroblast interaction and hypoxia promote inflammation and adipogenesis in Graves' orbitopathy","volume":"64","author":"G\u00f6rtz","year":"2022","journal-title":"Endocrinology"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/2528046","article-title":"Cytokines in thyroid-associated ophthalmopathy","volume":"2022","author":"Zhang","year":"2022","journal-title":"J Immunol Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2007.0405","article-title":"Cytokines, Graves' disease, and thyroid-associated ophthalmopathy","volume":"18","author":"Gianoukakis","year":"2008","journal-title":"Thyroid"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2023.101773","article-title":"Chemokines in thyroid autoimmunity","volume":"37","author":"Ferrari","year":"2023","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.574967","article-title":"Immunomodulatory function of vitamin D and its role in autoimmune thyroid disease","volume":"12","author":"Zhao","year":"2021","journal-title":"Front Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1145811","article-title":"Immunomodulatory role of vitamin D and selenium supplementation in newly diagnosed Graves' disease patients during methimazole treatment","volume":"14","author":"Gallo","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3390\/nu12051444","article-title":"Immunomodulatory effects of vitamin D in thyroid diseases","volume":"12","author":"Mele","year":"2020","journal-title":"Nutrients"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s43440-023-00567-0","article-title":"Safety of non-standard regimen of systemic steroid therapy in patients with Graves' orbitopathy: a single-centre experience","volume":"76","author":"Sawicka-Gutaj","year":"2024","journal-title":"Pharmacol Rep"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1186\/s13044-019-0074-0","article-title":"Life-threatening complications of high doses of intravenous methylprednisolone for treatment of Graves' orbitopathy","volume":"12","author":"Walasik-Szempli\u0144ska","year":"2019","journal-title":"Thyroid Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.08-2443","article-title":"Imatinib mesylate and AMN107 inhibit PDGF-signaling in orbital fibroblasts: a potential treatment for Graves' ophthalmopathy","volume":"50","author":"van Steensel","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2014.00123","article-title":"Fibroblasts in fibrosis: novel roles and mediators","volume":"5","author":"Kendall","year":"2014","journal-title":"Front Pharmacol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.181488","article-title":"Dynamic transition of Tregs to cytotoxic phenotype amid systemic inflammation in Graves' ophthalmopathy","volume":"9","author":"Liu","year":"2024","journal-title":"JCI Insight"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2807","article-title":"Mechanisms of fibrosis: therapeutic translation for fibrotic disease","volume":"18","author":"Wynn","year":"2012","journal-title":"Nat Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-1882","article-title":"IL-17A exacerbates fibrosis by promoting the proinflammatory and profibrotic function of orbital fibroblasts in TAO","volume":"101","author":"Fang","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.16-20199","article-title":"IL-17A promotes RANTES expression, but not IL-16, in orbital fibroblasts via CD40-CD40L combination in thyroid-associated ophthalmopathy","volume":"57","author":"Fang","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.619989","article-title":"Integrative analysis of proteomics and DNA methylation in orbital fibroblasts from Graves' ophthalmopathy","volume":"11","author":"Virakul","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.15-18763","article-title":"Coordinated regulation of palladin and \u03b1-smooth muscle actin by transforming growth factor-\u03b2 in human corneal fibroblasts","volume":"57","author":"Morishige","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00166.2024","article-title":"Interaction of MMP-9 in the active phase of Graves' disease with and without ophthalmopathy","volume":"327","author":"Riguetto","year":"2024","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.18-23951","article-title":"CD34- orbital fibroblasts from patients with thyroid-associated ophthalmopathy modulate TNF-\u03b1 expression in CD34+ fibroblasts and fibrocytes","volume":"59","author":"Lu","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B38","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.clbc.2017.04.007","article-title":"High ASMA","volume":"17","author":"Amornsupak","year":"2017","journal-title":"Clin Breast Cancer"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.2174\/1568010053586246","article-title":"Matrix metalloproteinase-9 and airway remodeling in asthma","volume":"4","author":"Ohbayashi","year":"2005","journal-title":"Curr Drug Targets Inflammation Allergy"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.114.19.3507","article-title":"Regulation of human lung fibroblast phenotype and function by vitronectin and vitronectin integrins","volume":"114","author":"Scaffidi","year":"2001","journal-title":"J Cell Sci"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2019.1629605","article-title":"The role of vitamin D receptor gene polymorphisms in thyroid-associated orbitopathy","volume":"28","author":"Maciejewski","year":"2020","journal-title":"Ocul Immunol Inflammation"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28010015","article-title":"Glucocorticoids directly affect hyaluronan production of orbital fibroblasts; a potential pleiotropic effect in Graves' orbitopathy","volume":"28","author":"Galgoczi","year":"2022","journal-title":"Molecules"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21155186","article-title":"The CCL20-CCR6 axis in cancer progression","volume":"21","author":"Kadomoto","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.122.001298","article-title":"Neutralizing MIP3","volume":"384","author":"Ekperikpe","year":"2023","journal-title":"J Pharmacol Exp Ther"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1016\/j.jaci.2013.12.004","article-title":"Anti-inflammatory and corticosteroid-enhancing actions of vitamin D in monocytes of patients with steroid-resistant and those with steroid-sensitive asthma","volume":"133","author":"Zhang","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1159\/000380882","article-title":"Vitamin D3 treatment decreases frequencies of CD16-positive and TNF-\u03b1-secreting monocytes in asthmatic patients","volume":"166","author":"Grubczak","year":"2015","journal-title":"Int Arch Allergy Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01865","article-title":"Interleukin-6 and type-I collagen production by systemic sclerosis fibroblasts are differentially regulated by interleukin-17A in the presence of transforming growth factor-beta 1","volume":"9","author":"Dufour","year":"2018","journal-title":"Front Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2016.11.025","article-title":"Transmembrane TNF-alpha reverse signaling leading to TGF-beta production is selectively activated by TNF targeting molecules: therapeutic implications","volume":"115","author":"Szondy","year":"2017","journal-title":"Pharmacol Res"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/det265","article-title":"Vitamin D3 inhibits expression and activities of matrix metalloproteinase-2 and -9 in human uterine fibroid cells","volume":"28","author":"Halder","year":"2013","journal-title":"Hum Reprod"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1728194\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T04:40:56Z","timestamp":1788928856000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1728194\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,9]]},"references-count":49,"alternative-id":["10.3389\/fimmu.2026.1728194"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1728194","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,9]]},"article-number":"1728194"}}